Poor metabolic control in childhood strongly correlates to diabetes-related premature death in persons <30 years of age-A population-based cohort study.


Journal

Pediatric diabetes
ISSN: 1399-5448
Titre abrégé: Pediatr Diabetes
Pays: Denmark
ID NLM: 100939345

Informations de publication

Date de publication:
05 2020
Historique:
received: 28 02 2019
revised: 15 11 2019
accepted: 09 01 2020
pubmed: 17 1 2020
medline: 16 6 2021
entrez: 17 1 2020
Statut: ppublish

Résumé

The importance of metabolic control in childhood regarding excess risk of death in young persons has not been well studied. This registry-based study aimed to investigate mortality rates and cause of death related to metabolic control in young persons (≤29 years) in Sweden with type 1 diabetes. All 12 652 subjects registered in the Swedish pediatric diabetes quality register, from 2006 to 2014, were included. Data were merged with the Swedish Cause of Death Register. Standardized mortality rates were calculated using the official Swedish population register. Of 68 deaths identified, 38.2% of the deaths were registered as being due to diabetes whereof the major cause of death was acute complications. Overall standardized mortality ratio was 2.7 (2.1-3.4, 95% CI). Subjects who died from diabetes had a mean HbA1c of 74 ± 19 mmol/mol (8.9 ± 1.7%) during childhood vs 62 ± 12 mmol/mol (7.8 ± 1.1%) in those still alive (P < .001). In this nationwide cohort of young subjects with type 1 diabetes, there was a high mortality rate compared to the general population. Mean HbA1c in childhood was significantly higher in those who died from diabetes, compared to subjects who were still alive. To decrease mortality in young persons with type 1 diabetes it is essential not only to achieve but also to maintain a good metabolic control during childhood and adolescence.

Sections du résumé

BACKGROUND/OBJECTIVE
The importance of metabolic control in childhood regarding excess risk of death in young persons has not been well studied. This registry-based study aimed to investigate mortality rates and cause of death related to metabolic control in young persons (≤29 years) in Sweden with type 1 diabetes.
METHODS
All 12 652 subjects registered in the Swedish pediatric diabetes quality register, from 2006 to 2014, were included. Data were merged with the Swedish Cause of Death Register. Standardized mortality rates were calculated using the official Swedish population register.
RESULTS
Of 68 deaths identified, 38.2% of the deaths were registered as being due to diabetes whereof the major cause of death was acute complications. Overall standardized mortality ratio was 2.7 (2.1-3.4, 95% CI). Subjects who died from diabetes had a mean HbA1c of 74 ± 19 mmol/mol (8.9 ± 1.7%) during childhood vs 62 ± 12 mmol/mol (7.8 ± 1.1%) in those still alive (P < .001).
CONCLUSIONS
In this nationwide cohort of young subjects with type 1 diabetes, there was a high mortality rate compared to the general population. Mean HbA1c in childhood was significantly higher in those who died from diabetes, compared to subjects who were still alive. To decrease mortality in young persons with type 1 diabetes it is essential not only to achieve but also to maintain a good metabolic control during childhood and adolescence.

Identifiants

pubmed: 31943577
doi: 10.1111/pedi.12980
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

479-485

Informations de copyright

© 2020 The Authors. Pediatric Diabetes published by John Wiley & Sons Ltd.

Références

Patterson CC, Dahlquist G, Harjutsalo V, et al. Early mortality in EURODIAB population-based cohorts of type 1 diabetes diagnosed in childhood since 1989. Diabetologia. 2007;50(12):2439-2442.
Morgan E, Cardwell CR, Black CJ, McCance DR, Patterson CC. Excess mortality in type 1 diabetes diagnosed in childhood and adolescence: a systematic review of population-based cohorts. Acta Diabetol. 2015;52(4):801-807.
Evans-Cheung TC, Bodansky HJ, Parslow RC, Feltbower RG. Mortality and acute complications in children and young adults diagnosed with type 1 diabetes in Yorkshire, UK: a cohort study. Diab Med: J Br Diab Assoc. 2018;35(1):112-120.
Dahlquist G, Kallen B. Mortality in childhood-onset type 1 diabetes: a population-based study. Diabetes Care. 2005;28(10):2384-2387.
Gagnum V, Stene LC, Sandvik L, et al. All-cause mortality in a nationwide cohort of childhood-onset diabetes in Norway 1973-2013. Diabetologia. 2015;58(8):1779-1786.
Harjutsalo V, Forsblom C, Groop PH. Time trends in mortality in patients with type 1 diabetes: nationwide population based cohort study. BMJ. 2011;343:d5364.
Morgan E, Black CR, Abid N, Cardwell CR, McCance DR, Patterson CC. Mortality in type 1 diabetes diagnosed in childhood in Northern Ireland during 1989-2012: a population-based cohort study. Pediatr Diabetes. 2018;19(1):166-170.
Sandahl K, Nielsen LB, Svensson J, et al. Increased mortality in a Danish cohort of young people with type 1 diabetes mellitus followed for 24 years. Diabet Med. 2017;34(3):380-386.
Cooper MN, de Klerk NH, Jones TW, Davis EA. Clinical and demographic risk factors associated with mortality during early adulthood in a population-based cohort of childhood-onset type 1 diabetes. Diab Med: J Br Diab Assoc. 2014;31(12):1550-1558.
Berhan Y, Waernbaum I, Lind T, Mollsten A, Dahlquist G. Thirty years of prospective nationwide incidence of childhood type 1 diabetes: the accelerating increase by time tends to level off in Sweden. Diabetes. 2011;60(2):577-581.
Incidence and trends of childhood type 1 diabetes worldwide 1990-1999. Diab Med: J the Br Diab Assoc. 2006;23(8):857-866.
Swediabkids. Annual Report 2016. [Web Page]. 2016; https://swediabkids.ndr.nu/Documents/NDR-Child/AnnualReport-2016.pdf. Accessed November 1, 2017.
Fullerton B, Jeitler K, Seitz M, Horvath K, Berghold A, Siebenhofer A. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus. Cochrane Database Syst Rev. 2014;2:CD009122.
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The diabetes control and complications trial research group. N Engl J Med. 1993;329(14):977-986.
Mortality in type 1 diabetes in the DCCT/EDIC versus the general population. Diabetes Care. 2016;39(8):1378-1383.
Svensson M, Eriksson JW, Dahlquist G. Early glycemic control, age at onset, and development of microvascular complications in childhood-onset type 1 diabetes: a population-based study in northern Sweden. Diabetes Care. 2004;27(4):955-962.
Samuelsson U, Steineck I, Gubbjornsdottir S. A high mean-HbA1c value 3-15 months after diagnosis of type 1 diabetes in childhood is related to metabolic control, macroalbuminuria, and retinopathy in early adulthood-a pilot study using two nation-wide population based quality registries. Pediatr Diabetes. 2014;15(3):229-235.
Nordwall M, Arnqvist HJ, Bojestig M, Ludvigsson J. Good glycemic control remains crucial in prevention of late diabetic complications-the Linkoping diabetes complications study. Pediatr Diabetes. 2009;10(3):168-176.
Anderzen J, Samuelsson U, Gudbjornsdottir S, Hanberger L, Akesson K. Teenagers with poor metabolic control already have a higher risk of microvascular complications as young adults. J Diabetes Complications. 2016;30(3):533-536.
Lind M, Svensson AM, Kosiborod M, et al. Glycemic control and excess mortality in type 1 diabetes. N Engl J Med. 2014;371(21):1972-1982.
Swediabkids. Annual Report 2013. [Web Page]. 2013; https://swediabkids.ndr.nu/ShowPDF.aspx?Document=NDR-Child/AnnualReport-2013.pdf. Accessed March 03, 2015.
Swedish Association of Local Authorities and Regions. Swedish Association of Local Authorities and Regions. [Web Page]. 2017; https://skl.se/english/. Accessed 30 October, 2017.
Hanas R, John G. 2010 consensus statement on the worldwide standardization of the hemoglobin A1C measurement. Diabetes Care. 2010;33(8):1903-1904.
The National Board of Health and Welfare. The Swedish Cause of Death Register. [Web Page]. 2017; http://www.socialstyrelsen.se/register/dodsorsaksregistret. Accessed 30 October, 2017.
Brooke HL, Talbäck M, Hörnblad J, et al. The Swedish cause of death register. Eur J Epidemiol. 2017;32(9):765-773.
Gagnum V, Stene LC, Jenssen TG, et al. Causes of death in childhood-onset type 1 diabetes: long-term follow-up. Diabet Med. 2017;34(1):56-63.
Buschur EO, Glick B, Kamboj MK. Transition of care for patients with type 1 diabetes mellitus from pediatric to adult health care systems. Trans Ped. 2017;6(4):373-382.
Samuelsson U, Anderzen J, Gudbjornsdottir S, Steineck I, Akesson K, Hanberger L. Teenage girls with type 1 diabetes have poorer metabolic control than boys and face more complications in early adulthood. J Diabetes Complications. 2016;30(5):917-922.
Rawshani A, Sattar N, Franzén S, et al. Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study. Lancet. 2018;392(10146):477-486.

Auteurs

John Samuelsson (J)

Department of Pediatrics, Ryhov County Hospital, Jönköping, Sweden.
Department of Clinical and Experimental Medicine, Division of Children's and Women's Health, Linköping University, Linköping, Sweden.

Ulf Samuelsson (U)

Department of Clinical and Experimental Medicine, Division of Children's and Women's Health, Linköping University, Linköping, Sweden.

Lena Hanberger (L)

Department of Medicine and Health Sciences, Division of Nursing, Linköping University, Linköping, Sweden.

Marie Bladh (M)

Department of Clinical and Experimental Medicine, Division of Children's and Women's Health, Linköping University, Linköping, Sweden.

Karin Åkesson (K)

Department of Pediatrics, Ryhov County Hospital, Jönköping, Sweden.
Department of Clinical and Experimental Medicine, Division of Children's and Women's Health, Linköping University, Linköping, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH